Sunflower Pharmaceutical Group (002737.SZ): The compound polyethylene glycol (3350) electrolyte oral solution has obtained a drug registration certificate.

date
15:51 24/02/2026
avatar
GMT Eight
Kuibao Pharmaceutical (002737.SZ) announces that its subsidiary has recently received the drug registration certificate issued by the National Medical Products Administration for the registered compound polyethylene glycol (3350) electrolyte oral solution. The related indications are for treating chronic constipation and fecal impaction.
Sunflower Pharmaceutical Group (002737.SZ) announced that its subsidiary recently received a drug registration certificate issued by the National Medical Products Administration for the approval of polyethylene glycol (3350) electrolyte oral solution. The indication is for the treatment of chronic constipation and fecal impaction.